Client Work Detail
matter
Valeant Canada Limited Acquires Laboratoire Dr Renaud
CLIENT
Valeant Canada Limited
DATE
December 15, 2009
EXPERTISE
Mergers and Acquisitions, Life Sciences, Trade-marks, Real Estate, Corporate and Commercial
LAWYER(S)
Steve Malas, Edouard Vo-Quang, Derek Chiasson, Miguel Manzano, Anne-Frédérique Bourret, Gino Martel
On December 15, 2009, Valeant Canada Limited and Valeant Pharmaceuticals North America, wholly-owned subsidiaries of Valeant Pharmaceuticals International (NYSE: VRX), completed the acquisition of Laboratoire Dr Renaud Inc. and Renaud Skin Care Laboratories, Inc. for an aggregate cash purchase price of $23 million. Laboratoire Dr. Renaud is a leading cosmeceutical company located in Laval, Quebec. As part of the transaction, Valeant (through its newly-acquired subsidiary) also entered into a lease for a state-of-the-art, 45,000 square foot facility that includes a manufacturing plant that was completed in 2007 specializing in topical formulations.
Steve Malas and Edouard Vo-Quang (Corporate and M&A), Miguel Manzano (Real Estate), Derek Chiasson (Tax), Anne-Frederique Bourret (Environmental) and Gino Martel of Ogilvy Renault LLP represented Valeant.
